|
1
|
Ryerson AB, Eheman CR, Altekruse SF, Ward
JW, Jemal A, Sherman RL, Henley SJ, Holtzman D, Lake A, Noone AM,
et al: Annual Report to the Nation on the Status of Cancer,
1975–2012, featuring the increasing incidence of liver cancer.
Cancer. 122:1312–1337. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Altekruse SF, Henley SJ, Cucinelli JE and
McGlynn KA: Changing hepatocellular carcinoma incidence and liver
cancer mortality rates in the United States. Am J Gastroenterol.
109:542–553. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Wang H and Chen L: Tumor microenviroment
and hepatocellular carcinoma metastasis. J Gastroenterol Hepatol.
28 (Suppl 1):S43–S48. 2013. View Article : Google Scholar
|
|
4
|
Lee MH, Kim EJ, Lee H, Kim HM, Chang MJ,
Park SY, Hong KS, Kim JS and Sessler JL: Liposomal texaphyrin
theranostics for metastatic liver cancer. J Am Chem Soc.
138:16380–16387. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Zhao X, Chen Q, Liu W, Li Y, Tang H, Liu X
and Yang X: Codelivery of doxorubicin and curcumin with lipid
nanoparticles results in improved efficacy of chemotherapy in liver
cancer. Int J Nanomedicine. 10:257–270. 2015.PubMed/NCBI
|
|
6
|
Esteller M: Non-coding RNAs in human
disease. Nat Rev Genet. 12:861–874. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Spizzo R, Almeida MI, Colombatti A and
Calin GA: Long non-coding RNAs and cancer: A new frontier of
translational research? Oncogene. 31:4577–4587. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Calin GA and Croce CM: MicroRNA signatures
in human cancers. Nat Rev Cancer. 6:857–866. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Kumarswamy R, Volkmann I and Thum T:
Regulation and function of miRNA-21 in health and disease. RNA
Biol. 8:706–713. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Pan X, Wang ZX and Wang R: MicroRNA-21: a
novel therapeutic target in human cancer. Cancer Biol Ther.
10:1224–1232. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Zhang L, Kang W, Lu X, Ma S, Dong L and
Zou B: lncRNA CASC11 promoted gastric cancer cell proliferation,
migration and invasion in vitro by regulating cell cycle pathway.
Cell Cycle. 17:1886–1900. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Chun YS, Pawlik TM and Vauthey JN: 8th
Edition of the AJCC cancer staging manual: Pancreas and
hepatobiliary cancers. Ann Surg Oncol. 25:845–847. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Briz O, Perez MJ and Marin JJ: Further
understanding of mechanisms involved in liver cancer
chemoresistance. Hepatoma Res. 3:22–26. 2017. View Article : Google Scholar
|
|
15
|
Mao B, Xiao H, Zhang Z, Wang D and Wang G:
MicroRNA-21 regulates the expression of BTG2 in HepG2 liver cancer
cells. Mol Med Rep. 12:4917–4924. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Wei J, Gao W, Zhu CJ, Liu YQ, Mei Z, Cheng
T and Shu YQ: Identification of plasma microRNA-21 as a biomarker
for early detection and chemosensitivity of non-small cell lung
cancer. Chin J Cancer. 30:407–414. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Si X, Zang R, Zhang E, Liu Y, Shi X, Zhang
E, Shao L, Li A, Yang N, Han X, et al: lncRNA H19 confers
chemoresistance in ERα-positive breast cancer through epigenetic
silencing of the pro-apoptotic gene BIK. Oncotarget. 7:81452–8146.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Shen CJ, Cheng YM and Wang CL: lncRNA PVT1
epigenetically silences miR-195 and modulates EMT and
chemoresistance in cervical cancer cells. J Drug Target.
25:637–644. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Zhou X, Ye F, Yin C, Zhuang Y, Yue G and
Zhang G: The interaction between miR-141 and lncRNA-H19 in
regulating cell proliferation and migration in gastric cancer. Cell
Physiol Biochem. 36:1440–1452. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Cao MX, Jiang YP, Tang YL and Liang XH:
The crosstalk between lncRNA and microRNA in cancer metastasis:
Orchestrating the epithelial-mesenchymal plasticity. Oncotarget.
8:12472–12483. 2017.PubMed/NCBI
|
|
21
|
Zhang Z, Zhou C, Chang Y, Zhang Z, Hu Y,
Zhang F, Lu Y, Zheng L, Zhang W and Li X and Li X: Long non-coding
RNA CASC11 interacts with hnRNP-K and activates the WNT/β-catenin
pathway to promote growth and metastasis in colorectal cancer.
Cancer Lett. 376:62–73. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Wu D, Shi M and Fan XD: Mechanism of
miR-21 via Wnt/β-catenin signaling pathway in human A549 lung
cancer cells and Lewis lung carcinoma in mice. Asian Pac J Trop
Med. 8:479–484. 2015. View Article : Google Scholar : PubMed/NCBI
|
